BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Frayman KB, Armstrong DS, Grimwood K, Ranganathan SC. The airway microbiota in early cystic fibrosis lung disease. Pediatr Pulmonol 2017;52:1384-404. [PMID: 28815937 DOI: 10.1002/ppul.23782] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Rossi GA, Morelli P, Galietta LJ, Colin AA. Airway microenvironment alterations and pathogen growth in cystic fibrosis. Pediatr Pulmonol 2019;54:497-506. [DOI: 10.1002/ppul.24246] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
2 Mottais A, Berchel M, Le Gall T, Sibiril Y, d'Arbonneau F, Laurent V, Jaffrès P, Montier T. Antibacterial and transfection activities of nebulized formulations incorporating long n-alkyl chain silver N-heterocyclic carbene complexes. International Journal of Pharmaceutics 2019;567:118500. [DOI: 10.1016/j.ijpharm.2019.118500] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
3 Till H, Kashofer K, Laje P, Elhaddad A, Warncke G, Gorkiewicz G, Singer G. Microbial Evidence in Congenital Pulmonary Airway Malformations of Young Asymptomatic Infants. Journal of Laparoendoscopic & Advanced Surgical Techniques 2019;29. [DOI: 10.1089/lap.2017.0456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Kevat AC, Carzino R, Vidmar S, Ranganathan S. Glycoprotein A as a biomarker of pulmonary infection and inflammation in children with cystic fibrosis. Pediatr Pulmonol 2019;55:401-6. [DOI: 10.1002/ppul.24558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Savant AP, Mccolley SA. Cystic fibrosis year in review 2017. Pediatr Pulmonol 2018;53:1307-17. [DOI: 10.1002/ppul.24081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Metwally AA, Ascoli C, Turturice B, Rani A, Ranjan R, Chen Y, Schott C, Faro A, Ferkol TW, Finn PW, Perkins DL. Pediatric lung transplantation: Dynamics of the microbiome and bronchiolitis obliterans in cystic fibrosis. J Heart Lung Transplant 2020;39:824-34. [PMID: 32580896 DOI: 10.1016/j.healun.2020.04.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Stick SM, Schultz A. Rebuttal from Stephen M. Stick and André Schultz. J Physiol 2018;596:3445-6. [PMID: 30014473 DOI: 10.1113/JP276145] [Reference Citation Analysis]
8 Estabrooks S, Brodsky JL. Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators. Int J Mol Sci 2020;21:E452. [PMID: 31936842 DOI: 10.3390/ijms21020452] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
9 Malhotra S, Limoli DH, English AE, Parsek MR, Wozniak DJ. Mixed Communities of Mucoid and Nonmucoid Pseudomonas aeruginosa Exhibit Enhanced Resistance to Host Antimicrobials. mBio 2018;9:e00275-18. [PMID: 29588399 DOI: 10.1128/mBio.00275-18] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 8.8] [Reference Citation Analysis]
10 Malhotra S, Hayes D Jr, Wozniak DJ. Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface. Clin Microbiol Rev 2019;32:e00138-18. [PMID: 31142499 DOI: 10.1128/CMR.00138-18] [Cited by in Crossref: 88] [Cited by in F6Publishing: 56] [Article Influence: 29.3] [Reference Citation Analysis]
11 Elgamal Z, Singh P, Geraghty P. The Upper Airway Microbiota, Environmental Exposures, Inflammation, and Disease. Medicina (Kaunas) 2021;57:823. [PMID: 34441029 DOI: 10.3390/medicina57080823] [Reference Citation Analysis]
12 Zhao CY, Hao Y, Wang Y, Varga JJ, Stecenko AA, Goldberg JB, Brown SP. Microbiome Data Enhances Predictive Models of Lung Function in People With Cystic Fibrosis. J Infect Dis 2021;223:S246-56. [PMID: 33330902 DOI: 10.1093/infdis/jiaa655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Dyon-Tafani V, Josse J, Safrani-Lahyani J, Assant-Trouillet S, Chiganne M, Vincent F, Montclos MP, Doleans-Jordheim A, Laurent F. Clinical evaluation of three chromogenic media for the isolation of Staphylococcus aureus in respiratory samples in patients with cystic fibrosis. Diagn Microbiol Infect Dis 2021;99:115201. [PMID: 33065460 DOI: 10.1016/j.diagmicrobio.2020.115201] [Reference Citation Analysis]
14 Sánchez-Bautista A, Rodríguez-Díaz JC, Garcia-Heredia I, Luna-Paredes C, Alcalá-Minagorre PJ. Airway microbiota in patients with paediatric cystic fibrosis: Relationship with clinical status. Enferm Infecc Microbiol Clin (Engl Ed) 2019;37:167-71. [PMID: 30827333 DOI: 10.1016/j.eimc.2018.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Frayman KB, Wylie KM, Armstrong DS, Carzino R, Davis SD, Ferkol TW, Grimwood K, Storch GA, Ranganathan SC. Differences in the lower airway microbiota of infants with and without cystic fibrosis. J Cyst Fibros 2019;18:646-52. [PMID: 30580994 DOI: 10.1016/j.jcf.2018.12.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
16 Needham PG, Goeckeler-Fried JL, Zhang C, Sun Z, Wetzel AR, Bertrand CA, Brodsky JL. SLC26A9 is selected for endoplasmic reticulum associated degradation (ERAD) via Hsp70-dependent targeting of the soluble STAS domain. Biochem J 2021;478:4203-20. [PMID: 34821356 DOI: 10.1042/BCJ20210644] [Reference Citation Analysis]
17 Haiko J, Saeedi B, Bagger G, Karpati F, Özenci V. Coexistence of Candida species and bacteria in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2019;38:1071-7. [PMID: 30739228 DOI: 10.1007/s10096-019-03493-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
18 Loman BR, Shrestha CL, Thompson R, Groner JA, Mejias A, Ruoff KL, O'Toole GA, Bailey MT, Kopp BT. Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis. Pediatr Pulmonol 2020;55:1661-70. [PMID: 32275127 DOI: 10.1002/ppul.24766] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
19 de Almeida OGG, Capizzani CPDC, Tonani L, Grizante Barião PH, da Cunha AF, De Martinis ECP, Torres LAGMM, von Zeska Kress MR. The Lung Microbiome of Three Young Brazilian Patients With Cystic Fibrosis Colonized by Fungi. Front Cell Infect Microbiol 2020;10:598938. [PMID: 33262957 DOI: 10.3389/fcimb.2020.598938] [Reference Citation Analysis]
20 Kumpitsch C, Koskinen K, Schöpf V, Moissl-Eichinger C. The microbiome of the upper respiratory tract in health and disease. BMC Biol 2019;17:87. [PMID: 31699101 DOI: 10.1186/s12915-019-0703-z] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 22.3] [Reference Citation Analysis]
21 Purcaro G, Rees CA, Melvin JA, Bomberger JM, Hill JE. Volatile fingerprinting of Pseudomonas aeruginosa and respiratory syncytial virus infection in an in vitro cystic fibrosis co-infection model. J Breath Res 2018;12:046001. [PMID: 29735804 DOI: 10.1088/1752-7163/aac2f1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]